Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 4/2019

01-12-2019 | Original Research

The Potential Role of TNF-α (rs361525 and rs1800629) in Hepatocellular Carcinoma: Multivariate Analysis (Meta-Analysis)

Authors: Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Masoud Sheidai

Published in: Journal of Gastrointestinal Cancer | Issue 4/2019

Login to get access

Abstract

Purpose

Tumor necrosis factor-α has been suggested to play a crucial role in the development andprogression of hepatocellular carcinoma (HCC). Previous reports have indicated that rs361525 and rs1800629 might be risk factors for various cancers. Increasing studies have been conducted on the association of these two SNPs with HCC risk but the results remain inconclusive.

Methods

In order to detect association between TNF- α and HCC, a meta-analysis was performed. Five studies with 541 cases and 795 controls were used for rs361525, while six studies including 925 cases and 1307 controls were collected for investigating rs1800629. The grouping of countries from data were obtained was done by Principal Coordinate Analysis plot (PCA). Moreover, association between geographical area and grouping of genotypes was determined by Canonical Correspondence Analysis (CCA).

Results

Our meta-analysis showed that rs361525 and rs1800629 were not significantly associated with the risk of HCC. CCA analysis illustrated that there was not any correlation between genotype distribution and geographical distance for rs1800629 but there was significant correlation between genotype distribution and geographical features for rs361525. PCA analysis for both SNPs showed India and Korea were placed near each other and also China and Brazil were in same part of PCA plot.

Conclusion

To sum up, this meta-analysis suggests that the rs361525 and rs1800629 are not associated with HCC development while geographical distance effect on rs361525 genetic inheritance but not effect on rs1800629. However, it is necessary to conduct further studies with larger sample. Moreover, gene-gene and gene-environment interactions should also be considered.
Literature
1.
go back to reference Shin SP, Kim NK, Kim JH, Lee JH, Kim JO, Cho SH, et al. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea. World J Gastroenterol. 2015;21(46):13064.CrossRef Shin SP, Kim NK, Kim JH, Lee JH, Kim JO, Cho SH, et al. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea. World J Gastroenterol. 2015;21(46):13064.CrossRef
2.
go back to reference Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.CrossRef Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.CrossRef
3.
go back to reference Ploss A, Dubuisson J. New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets. Gut. 2012;61(Suppl 1):i25–35.CrossRef Ploss A, Dubuisson J. New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets. Gut. 2012;61(Suppl 1):i25–35.CrossRef
4.
go back to reference Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013;13(2):123–35.CrossRef Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013;13(2):123–35.CrossRef
5.
go back to reference Mimi CY, Yuan J-M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127(5):S72–8.CrossRef Mimi CY, Yuan J-M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127(5):S72–8.CrossRef
6.
go back to reference Zani C, Gelatti U, Donato F, Capelli M, Portolani N, Bergonzi R, et al. Polychlorinated biphenyls in serum, liver and adipose tissue of subjects with hepatocellular carcinoma living in a highly polluted area. Chemosphere. 2013;91(2):194–9.CrossRef Zani C, Gelatti U, Donato F, Capelli M, Portolani N, Bergonzi R, et al. Polychlorinated biphenyls in serum, liver and adipose tissue of subjects with hepatocellular carcinoma living in a highly polluted area. Chemosphere. 2013;91(2):194–9.CrossRef
7.
go back to reference Balkwill F. TNF-α in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25(3):409–16.CrossRef Balkwill F. TNF-α in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25(3):409–16.CrossRef
8.
go back to reference Kushibiki S. Tumor necrosis factor-α-induced inflammatory responses in cattle. Anim Sci J. 2011;82(4):504–11.CrossRef Kushibiki S. Tumor necrosis factor-α-induced inflammatory responses in cattle. Anim Sci J. 2011;82(4):504–11.CrossRef
9.
go back to reference Lejeune FJ, Rüegg C, Liénard D. Clinical applications of TNF-α in cancer. Curr Opin Immunol. 1998;10(5):573–80.CrossRef Lejeune FJ, Rüegg C, Liénard D. Clinical applications of TNF-α in cancer. Curr Opin Immunol. 1998;10(5):573–80.CrossRef
10.
go back to reference Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13(2):135–41.CrossRef Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13(2):135–41.CrossRef
11.
go back to reference Wilson A, De Vries N, Fd P, Di Giovine F, Van der Putte L, Duff G. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993;177(2):557–60.CrossRef Wilson A, De Vries N, Fd P, Di Giovine F, Van der Putte L, Duff G. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993;177(2):557–60.CrossRef
12.
go back to reference Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, et al. TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997;72(2):149–53.CrossRef Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, et al. TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997;72(2):149–53.CrossRef
13.
go back to reference Hajeer AH, Hutchinson IV. TNF-α gene polymorphism: clinical and biological implications. Microsc Res Tech. 2000;50(3):216–28.CrossRef Hajeer AH, Hutchinson IV. TNF-α gene polymorphism: clinical and biological implications. Microsc Res Tech. 2000;50(3):216–28.CrossRef
14.
go back to reference Bayley J-P, de Rooij H, van Den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the− 376,− 308,− 244, and− 238 polymorphic sites of the TNF-α promoter. Cytokine. 2001;14(6):316–23.CrossRef Bayley J-P, de Rooij H, van Den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the− 376,− 308,− 244, and− 238 polymorphic sites of the TNF-α promoter. Cytokine. 2001;14(6):316–23.CrossRef
15.
go back to reference Scardapane A, Breda L, Lucantoni M, Chiarelli F. TNF-α polymorphisms in juvenile idiopathic arthritis: which potential clinical implications? Int J Rheumatol. 2012;2012:1–16.CrossRef Scardapane A, Breda L, Lucantoni M, Chiarelli F. TNF-α polymorphisms in juvenile idiopathic arthritis: which potential clinical implications? Int J Rheumatol. 2012;2012:1–16.CrossRef
16.
go back to reference Kroeger KM, Carville KS, Abraham LJ. The− 308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol. 1997;34(5):391–9.CrossRef Kroeger KM, Carville KS, Abraham LJ. The− 308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol. 1997;34(5):391–9.CrossRef
17.
go back to reference Wilson A, Di Giovine F, Blakemore A, Duff G. Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by Ncol restriction of PCR product. Hum Mol Genet. 1992;1(5):353.CrossRef Wilson A, Di Giovine F, Blakemore A, Duff G. Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by Ncol restriction of PCR product. Hum Mol Genet. 1992;1(5):353.CrossRef
18.
go back to reference Huang H, Xie J-S, Huang Z-S, Zhao Q. The relationship of polymorphism of tumor necrosis factor-α gene promoter-238G/A with primary hepatic carcinoma in patients. Prog Anat Sci. 2007;13:11–3. Huang H, Xie J-S, Huang Z-S, Zhao Q. The relationship of polymorphism of tumor necrosis factor-α gene promoter-238G/A with primary hepatic carcinoma in patients. Prog Anat Sci. 2007;13:11–3.
19.
go back to reference Tian X, Ma P, Sui C, Li Y, Fu L, Jiang T, et al. Comprehensive assessment of the association between tumor necrosis factor alpha G238A polymorphism and liver cancer risk. Tumor Biol. 2014;35(1):103–9.CrossRef Tian X, Ma P, Sui C, Li Y, Fu L, Jiang T, et al. Comprehensive assessment of the association between tumor necrosis factor alpha G238A polymorphism and liver cancer risk. Tumor Biol. 2014;35(1):103–9.CrossRef
20.
go back to reference Jung KW, Ha E, Im Yu G, Kim SJ, Chung WJ, Jang BK, et al. TNFα promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta. 2009;407(1):16–9.CrossRef Jung KW, Ha E, Im Yu G, Kim SJ, Chung WJ, Jang BK, et al. TNFα promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta. 2009;407(1):16–9.CrossRef
21.
go back to reference Chen X, Zhang L, Chang Y, Shen T, Wang L, Zhuang H, et al. Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a Han Chinese population. Int J Biol Markers. 2011;26(3):181–7.CrossRef Chen X, Zhang L, Chang Y, Shen T, Wang L, Zhuang H, et al. Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a Han Chinese population. Int J Biol Markers. 2011;26(3):181–7.CrossRef
22.
go back to reference Feng H, Kuai J-H, Zhang M-Y, Wang G-C, Shi Y-J, Zhang J-Y. Tumor necrosis factor-alpha gene− 308G> A polymorphism alters the risk of hepatocellular carcinoma in a Han Chinese population. Diagn Pathol. 2014;9(1):199.CrossRef Feng H, Kuai J-H, Zhang M-Y, Wang G-C, Shi Y-J, Zhang J-Y. Tumor necrosis factor-alpha gene− 308G> A polymorphism alters the risk of hepatocellular carcinoma in a Han Chinese population. Diagn Pathol. 2014;9(1):199.CrossRef
23.
go back to reference Jeng J-S, Tsai J-F, Chuang L-Y, Ho M-S, Lin Z-Y, Hsieh M-Y, et al. Tumor necrosis factor-α 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia. 2007;9(11):987–92.CrossRef Jeng J-S, Tsai J-F, Chuang L-Y, Ho M-S, Lin Z-Y, Hsieh M-Y, et al. Tumor necrosis factor-α 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia. 2007;9(11):987–92.CrossRef
24.
go back to reference Yang Y, Qiu X-Q, Zeng X-Y, Bei C-H: Correlation of polymorphism of TNF-α gene promoter with susceptibility to hepatocellular carcinoma in Guangxi. China Oncology 2012, 12:3541. Yang Y, Qiu X-Q, Zeng X-Y, Bei C-H: Correlation of polymorphism of TNF-α gene promoter with susceptibility to hepatocellular carcinoma in Guangxi. China Oncology 2012, 12:3541.
25.
go back to reference Akkız H, Bayram S, Bekar A, Özdil B, Akgöllü E, Sümbül AT, et al. G-308A TNF-α polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol. 2009;33(3):261–4.CrossRef Akkız H, Bayram S, Bekar A, Özdil B, Akgöllü E, Sümbül AT, et al. G-308A TNF-α polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol. 2009;33(3):261–4.CrossRef
26.
go back to reference Hammer Ø, Harper D, Ryan P. Paleontological statistics software: package for education and data analysis. Palaeontol Electron. 2001;4 Hammer Ø, Harper D, Ryan P. Paleontological statistics software: package for education and data analysis. Palaeontol Electron. 2001;4
27.
go back to reference Teixeira A, Mendes-Junior C, Marano L, Deghaide N, Secaf M, Elias-Junior J, et al. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil. Hum Immunol. 2013;74(8):1024–9.CrossRef Teixeira A, Mendes-Junior C, Marano L, Deghaide N, Secaf M, Elias-Junior J, et al. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil. Hum Immunol. 2013;74(8):1024–9.CrossRef
28.
go back to reference Sghaier I, Zidi S, Mouelhi L, Dabbech R, Ghazouani E, Brochot E, et al. The relationship between TNF alpha gene polymorphisms (− 238/− 308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population. Gene. 2015;568(2):140–5.CrossRef Sghaier I, Zidi S, Mouelhi L, Dabbech R, Ghazouani E, Brochot E, et al. The relationship between TNF alpha gene polymorphisms (− 238/− 308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population. Gene. 2015;568(2):140–5.CrossRef
29.
go back to reference Li Y, Ou C, Shu H, Zhao H, Zhu B. The ERCC1-4533/8092, TNF-α 238/308 polymorphisms and the risk of hepatocellular carcinoma in Guangxi Zhuang populations of China: case-control study. Medicine. 2016;95(44):e5217.CrossRef Li Y, Ou C, Shu H, Zhao H, Zhu B. The ERCC1-4533/8092, TNF-α 238/308 polymorphisms and the risk of hepatocellular carcinoma in Guangxi Zhuang populations of China: case-control study. Medicine. 2016;95(44):e5217.CrossRef
30.
go back to reference Panigrahi R, Sarkar N, Biswas A, Pal A, Saha D, Singh SP, et al. Association of TNF-α promoter polymorphism with HBV associated disease outcome among HBV infected patients from Orissa, southern part of East India. J Clin Exp Hepatol. 2014;4(3):202–8.CrossRef Panigrahi R, Sarkar N, Biswas A, Pal A, Saha D, Singh SP, et al. Association of TNF-α promoter polymorphism with HBV associated disease outcome among HBV infected patients from Orissa, southern part of East India. J Clin Exp Hepatol. 2014;4(3):202–8.CrossRef
31.
go back to reference Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.CrossRef Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.CrossRef
32.
go back to reference Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53(3):508–18.CrossRef Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53(3):508–18.CrossRef
33.
go back to reference Azar SS, Mansoori M, Attar M, Shahbazi M. Tumor necrosis factor alpha 308 G/A single nucleotide polymorphism and susceptibility to hepatocellular carcinoma via hepatitis B infection. Asian Pac J Cancer Prev. 2016;17:3381–4.PubMed Azar SS, Mansoori M, Attar M, Shahbazi M. Tumor necrosis factor alpha 308 G/A single nucleotide polymorphism and susceptibility to hepatocellular carcinoma via hepatitis B infection. Asian Pac J Cancer Prev. 2016;17:3381–4.PubMed
34.
go back to reference Verma I, Kaur J. Roli Saxena, Yogesh Kumar Chawla. Verma I, Kaur J. Roli Saxena, Yogesh Kumar Chawla.
35.
go back to reference Kew M. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol. 2010;58(4):273–7.CrossRef Kew M. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol. 2010;58(4):273–7.CrossRef
36.
go back to reference Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One. 2009;4(4):e5360.CrossRef Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One. 2009;4(4):e5360.CrossRef
Metadata
Title
The Potential Role of TNF-α (rs361525 and rs1800629) in Hepatocellular Carcinoma: Multivariate Analysis (Meta-Analysis)
Authors
Mehdi Heidari Horestani
Golnaz Atri Roozbahani
Masoud Sheidai
Publication date
01-12-2019
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 4/2019
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0135-y

Other articles of this Issue 4/2019

Journal of Gastrointestinal Cancer 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine